NCT03691012
Who may be able to join
Who might be able to join this trial:
- You have had surgery to remove ovarian, fallopian tube, or peritoneal cancer (specific types: high grade serous, endometrioid, clear cell carcinoma, or carcinosarcoma) at stage I through IV, and the surgeon was able to remove all visible cancer — OR you are about to start chemotherapy before surgery (called neoadjuvant chemotherapy) for stage I–III of these same cancer types, with surgery planned during or after that chemotherapy.
- A tumour tissue sample (taken during surgery or by a biopsy before chemotherapy) can be provided for laboratory testing.
- You are well enough and are planned to receive chemotherapy after surgery.
Who may not be able to join:
- You have been diagnosed with another type of cancer in the past 3 years.
- Your ovarian, fallopian tube, or peritoneal cancer is of the mucinous type, or is a sarcoma.
- You have stage IV cancer where not all visible cancer could be removed during surgery (i.e., some cancer was left behind).
- You are under 18 years of age.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
6 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Circulating DNA in the plasma of cancer patients has been shown to exhibit tumour-related alteration. These mutations in tumour cells,can be used as highly specific biomarkers of disease burden. Baseline.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.